This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Is KHC's Pricing Strategy Enough to Sustain Growth Amid Challenges?
by Zacks Equity Research
Kraft Heinz is maintaining profitability through effective pricing strategies and operational agility despite facing challenges from declining consumer demand.
KDP Stock Rises 23% in the Past Six Months: Time to Buy, Sell or Hold?
by Zacks Equity Research
Keurig Dr Pepper gains from brand strength, pricing actions and solid performance in its Refreshment Beverages segment.
McCormick Q3 Earnings Top Estimates, MKC Volumes Improve Y/Y
by Zacks Equity Research
McCormick's Q3 results reflect positive volume growth, indicating improving trends across both business segments.
Grocery Outlet Trades Below 200 & 50-Day SMA: How to Play the Stock?
by Zacks Equity Research
The system transition, which has posed challenges for GO, is negatively impacting its operational efficiency and financial performance.
Diageo Completes Sale of Its Guinness Nigeria Share to Tolaram
by Zacks Equity Research
DEO benefits from its focus on improving productivity, coupled with its diversified footprint. It concludes the sale of its shareholding in Guinness Nigeria PLC to Tolaram.
CENT Declines 23% From 52-Week High: Will the Stock Rebound?
by Zacks Equity Research
Central Garden & Pet is grappling with sales declines in the Pet and Garden segments due to macroeconomic factors and adverse weather.
Kimberly-Clark Stock Trading Above 200 & 50-Day SMA: Should You Buy?
by Zacks Equity Research
KMB is demonstrating strong market resilience and growth with a volume-plus-mix approach, ongoing transformation and investments in innovation and efficiency.
Tyson Foods' Operational Strategies Aid Amid Beef Segment Hurdles
by Zacks Equity Research
TSN's operational excellence, customer and consumer obsession, and Chicken unit strength keep it well-positioned amid Beef unit challenges.
Hershey Declines 10% From 52-Week High: Will the Stock Rebound?
by Zacks Equity Research
Though HSY is dealing with rising input costs, shrinking margins and increased price sensitivity in its chocolate segment, it still holds long-term potential.
Molson Coors Stock Falls 19% in Six Months: Time to Hold or Fold?
by Zacks Equity Research
TAP benefits from premiumization initiatives, innovation plans and solid brand performance while navigating higher costs.
Why Investors Should Watch COTY Stock Amid Booming Beauty Industry?
by Zacks Equity Research
Coty is capitalizing on the growing beauty market via strategic expansion in consumer beauty and fragrances, innovation and e-commerce growth.
Here's Why Flowers Foods (FLO) is a Strong Value Stock
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Archer Daniels Dips 14% YTD: Should You Buy, Sell or Hold ADM?
by Zacks Equity Research
ADM's margin pressures across its segments indicate investor concerns about the company's profitability.
What's Ahead for Inter Parfums in the Booming Fragrance Market?
by Zacks Equity Research
IPAR is leveraging positive fragrance market trends and strong new licenses amid an elevated cost environment.
Why Flowers Foods (FLO) is a Top Momentum Stock for the Long-Term
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Sysco's Secret Sauce: How SYY Stock is Positioned for Growth
by Zacks Equity Research
Sysco's focus on operational efficiency, customer support and its Recipe for Growth plan positions it well for long-term success despite challenges.
Mondelez Stock Trading Above 200 & 50-Day SMA: How to Play Ahead?
by Zacks Equity Research
Mondelez is gaining on pricing initiatives, cost control and a focus on core categories, while high cocoa prices and inflationary pressures raise concerns.
Nu Skin Trading Near 52-Week Low: Should You Buy or Sell NUS Stock?
by Zacks Equity Research
Nu Skin is facing macroeconomic difficulties and a slow-moving direct-selling market. Foreign currency headwinds are also weighing on NUS.
Is CHD Stock a Buy, Sell or Hold at a P/E Multiple of 28.4X?
by Zacks Equity Research
CHD is battling rising marketing costs and fluctuating consumer spending, while a solid brand image, innovative products and strategic expansions bode well.
MDLZ to Fuel Presence in Cakes & Pastries Market With Evirth Deal
by Zacks Equity Research
Mondelez is acquiring a majority stake in Evirth to enhance its presence in the growing cakes and pastries market as part of its broader strategic focus.
Will Growth Strategies Propel Colgate's Stock to New Heights?
by Zacks Equity Research
CL is on a growth track, backed by its innovation strategy, aggressive pricing actions and productivity initiatives.
What Does Philip Morris's Sale of Vectura Group Mean for its Future? (Revised)
by Zacks Equity Research
PM sells Vectura Group to Molex Asia Holdings amid criticism of its ownership as it seeks to shift from tobacco to healthcare.
Is Holding Vital Farms Stock a Wise Call After 40% Gain in Six Months?
by Sumit Singh
Vital Farms' market expansion and decent Q2 2024 results may encourage shareholders to stay on board for continued growth potential.
Monster Beverage's Expansion Strategy Aids: Apt to Hold the Stock?
by Zacks Equity Research
MNST sees strength in its energy drinks category. Its expansion strategy also bodes well.
Helen of Troy Stock Falls 40% in Three Months: What's Next for HELE?
by Zacks Equity Research
HELE is battling operational challenges, rising costs and macroeconomic uncertainty, leading to a weaker fiscal 2025 outlook.